Suspect Detection Systems Receives Funding From Israel-Publicly Traded Biomedix Ltd.

    Suspect Detection Systems Receives Funding From Israel-Publicly Traded
                                Biomedix Ltd.

PR Newswire

NEW YORK, April 3, 2013

NEW YORK, April 3, 2013 /PRNewswire/ --

Funding can support enhancing the Cogito Solution's marketing efforts, that
management believe, can assist in Preventing Potential School/Mall Massacres

Suspect Detection Systems Inc. (OTCBB: SDSS), (SDSS.pk), a developer of
counter terror and crime prevention technology, today announced thatit has
entered into a share swap agreement with BioMedix Ltd., a publicly traded
company on the Tel Aviv Stock Exchange (TASE). BioMedix, a leading Medical
Device/Technology incubator, hasagreed to purchase5,229,659 restricted SDSS
shares at a valuation of $.04 per SDSS share, via share swap of its publicly
traded Israeli subsidiary, Gefen Biomed Investments Ltd.(GEFEN:TASE). In
connection with this share swap transaction; SDSS received 921,790 shares of
Gefen, which values the sdss shares at $.04 at the transaction's date.

The transaction with BioMedix was disclosed at the IL Maya system (Israeli SEC
website) and can be viewed (in Hebrew) at:

http://maya.tase.co.il/bursa/report.asp?report_cd=790991-00&CompCd=368&Type=Pdf

Gil Boosidan Suspect Detection Systems Inc.'s CEO, stated "SDSS continues to
progress in its efforts to bring added value to our shareholders. The funding
that we receive upon from our sale of our Gefen shares can be used to enhance
our ability to add personnel and acquire resourcesand support our marketing
efforts to achieve projectswithstrategic partners. We believe that the need
and desire, in the US, to prevent these nonsense acts of violent on US school
grounds and malls can be better pursued with the use of the Cogito solution.

Mr. Boosidan further stated that "Suspect Detection Systems Inc.is
continuing its efforts to improve cash flow, which will also improve our
financial condition and should result in share priceappreciation. Our
long-term planincludes seekingto upgrade our share listings tohigher level
exchanges including foreign listings in the future."

About Suspect Detection Systems

Suspect Detection Systems Inc., through its subsidiary Suspect Detection
Systems Ltd., is a developer of proprietary counter terrorism and crime
prevention technology designed to identify threats in real-time, and prevent
incidents before they are carried out. The technology detects the hidden
"hostile intent" of assailants - before they commit their intended acts - with
a high degree of accuracy. The system can also be used after a crime is
committed to quickly identify criminals from among a general population pool,
including suspects.

Learn more about Suspect Detection Systems and Cogito Technology at
http://www.sdss-corp.com.

About Biomedix and Gefen: Biomedix and its subsidiary, Gefen, are
Israel-based, publicly-traded companies listed on TASE. Biomedix is an
investment management company focused primarily on Israeli-based Medical
Device andTechnology companies, from early stage to later stage/mature
companies presenting high growth potential. Biomedix controls two of Israel's
largest incubators, ATI and Meytav, as well as a late-stage investment entity,
SpearHead. Gefen's risk management leverages its investment funds through the
Israeli incubator program under the direction of the Office of the Israel
Chief Scientist.

More information on BioMedix and Gefen can be found at:
http://www.biomedixincubator.com and http://www.gefenbiomed.com/,
respectively.

Forward-Looking Statements:

This release contains forward-looking statements within the meaning of Section
27A of the Securities Act of 1933 as amended and Section 21E of the Securities
Exchange Act of 1934 as amended. All forward-looking statements are inherently
uncertain, based on current expectations and assumptions concerning future
events or future performance of Suspect Detection Systems Inc., and its
technologies. In evaluating such statements, prospective investors should
review carefully various risks and uncertainties identified in this release,
as actual results may differ materially from those indicated. Suspect
Detection Systems Inc. public filings may be viewed athttp://www.sec.gov.

Contact:
Investor Relations
alext@sdss-corp.com
+1(646)863-9729

SOURCE Suspect Detection Systems